On February 13, 2026, a putative class filed a Complaint in the U.S. District Court for the Northern District of Illinois alleging that Tempus AI, Inc. (“Tempus AI”) violated the Illinois Genetic Information Privacy Act (410 ILCS 513/1 et seq., “GIPA ”). The plaintiffs claim Tempus AI unlawfully obtained and disclosed genetic information belonging to customers of Ambry Genetics Corporation (“Ambry Genetics”) in connection with Tempus AI’s February 2025 acquisition of 100% of Ambry’s equity….
By: Alston & Bird
By: Alston & Bird
